跳至主要内容
临床试验/NCT06182982
NCT06182982尚未招募不适用

Efficacy of Auriculotherapy Medical Devices in Intraoperative Blood Pressure Control During Endoscopic Sinus Surgery, a Prospective Randomized Controlled Study.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2024年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
32
试验地点
2
主要终点
Nitroglycerin

研究概览

简要总结

The endoscopic surgery of the paranasal sinuses (FESS) requires careful control of arterial pressure to prevent bleeding of the nasal mucosa that may lead to a reduction in the visual field. However, controlled reversible hypotension has been associated with phenomena of peripheral hypoperfusion with possible organ damage on an ischemic basis. Based on the data available in the literature, a mean arterial pressure (MAP) target between 50 and 65 mmHg is considered acceptable. Although blood pressure control is generally ensured through intravenous pharmacological approaches, there is evidence of efficacy with the use of Auriculotherapy medical devices (stimulation of specific points in the ear through the application of Magnetic ball plasters).

Proposed pharmacological choices to achieve this result have been multiple, although totally intravenous anesthesia with propofol and opioids seems to be more effective than balanced anesthesia with halogenated agents and opioids. However, this fundamental option requires the administration of antihypertensive drugs to achieve the blood pressure target. Despite common contraindications to individual pharmacological classes, various active principles have been compared. Among these, continuous low-dose nitroglycerin infusion has proven effective due to titratability linked to its short half-life, perioperative complications, and better conditions of peripheral perfusion compared to beta-blockers such as labetalol or esmolol.

Based on existing literature data, in our hospital, general anesthesia is typically conducted with intravenous techniques and the continuous administration of low doses of nitroglycerin in continuous infusion (0.01-2 mcg/kg/min). Despite the low dosages, this drug can be burdened with dosage-dependent adverse effects such as orthostatic hypotension, tachycardia, or headache. To reduce the dosage of nitroglycerin, we have borrowed from different contexts hypotensive auriculotherapy techniques (stimulation of specific ear points through the application of magnetic ball plasters), which have proven effective in managing systemic pressure in patients with essential hypertension.

These non-pharmacological techniques, already used during general anesthesia for the management of nausea and pain, could prove promising in reducing the use of antihypertensive drugs even in the intraoperative context. The primary hypothesis of our study is that the use of Auriculotherapy medical devices is effective in achieving a hypotensive effect in patients undergoing general anesthesia during FESS surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of both sexes to undergo Functional Endoscopic Sinus Surgery (FESS) under General Anesthesia
  • Patients aged between 18 and 69 years
  • History of well-controlled essential hypertension under pharmacological treatment for at least one year
  • ASA Class II-III.

排除标准

  • Age < 18 years;
  • Pregnancy status;
  • NYHA class > III;
  • ASA class > III;
  • BMI > 35;
  • Positive history of Myocardial Infarction or neurovascular diseases;
  • Previous treatment with antineoplastic agents;
  • Secondary hypertension;
  • Uncontrolled hypertension despite therapy (MAP > 125 in preoperative visit);
  • Anatomic alterations of the auricles;
  • Presence of carotid stenosis > 50%;
  • Allergy or intolerance to drugs specified in the clinical protocol;
  • Nickel or metal allergy present in magnetic spheres;
  • Refusal of informed consent or inability to express it

结局指标

主要结局

Nitroglycerin

时间窗: at the end of surgery

Reduction in the amount of intravenous nitroglycerin (mcg/kg/min) administered during FESS surgery

次要结局

  • Blood pressure(24 hours)
  • Surgeon(at the end of surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验